Correction: Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner (Proceedings of the National Academy of Sciences of the United States of America (2017) 114 (E961-E969) DOI: 10.1073/pnas.1613305114);Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 6, 2017, Pages E961-E969

  Conos, Stephanie A ^a,b   Chen, Kaiwen W ^c   De Nardo, Dominic ^a,b   Hara, Hideki ^d   Whitehead, Lachlan ^a,b   Núñez, Gabriel ^d   Masters, Seth L ^a,b   Murphy, James M ^a,b   Schroder, Kate ^c   Vaux, David L ^a,b   Lawlor, Kate E ^a,b   Lindqvist, Lisa M ^a,b   Vince, James E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Gasdermin D; Interleukin 1 ; MLKL; Necroptosis; NLRP3

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; MLKL PROTEIN, MOUSE; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK3 PROTEIN, MOUSE;

ARTICLE; CELL DEATH; CELL MEMBRANE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; NECROPTOSIS; OLIGOMERIZATION; POTASSIUM CELL LEVEL; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYROPTOSIS; ANIMAL; APOPTOSIS; BONE MARROW CELL; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MOUSE; NECROSIS; PROTEIN MULTIMERIZATION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CASPASE 1; CELL LINE, TUMOR; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, KNOCKOUT; NECROSIS; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PROTEIN KINASES; PROTEIN MULTIMERIZATION; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 85011632943     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1710668114     Document Type: Erratum

References (62)

1. Ebert G, et al. (2015) Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis. Proc Natl Acad Sci USA 112(18):5803-5808.
2. Speir M, et al. (2016) Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis. Nat Microbiol 1:15034.
3. Mocarski ES, Kaiser WJ, Livingston-Rosanoff D, Upton JW, Daley-Bauer LP (2014) True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol 192(5):2019-2026.
4. Silke J, Rickard JA, Gerlic M (2015) The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol 16(7):689-697.
5. Murphy JM, Vince JE (2015) Post-Translational control of RIPK3 and MLKL mediated necroptotic cell death. F1000Res 4:4.
6. Li J, et al. (2012) The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 150(2):339-350.
7. Murphy JM, et al. (2013) The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 39(3):443-453.
8. Rodriguez DA, et al. (2016) Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death Differ 23(1):76-88.
9. Sun L, et al. (2012) Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1-2):213-227.
10. Cai Z, et al. (2014) Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 16(1):55-65.
11. Chen X, et al. (2014) Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res 24(1):105-121.
12. Wang H, et al. (2014) Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell 54(1):133-146.
13. Dondelinger Y, et al. (2014) MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep 7(4):971-981.
14. Hildebrand JM, et al. (2014) Activation of the pseudokinase MLKL unleashes the fourhelix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci USA 111(42):15072-15077.
15. Tanzer MC, et al. (2016) Evolutionary divergence of the necroptosis effector MLKL. Cell Death Differ 23(7):1185-1197.
16. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G (2010) Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 11(10): 700-714.
17. Lawlor KE, et al. (2015) RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 6:6282.
18. Kang TB, Yang SH, Toth B, Kovalenko A, Wallach D (2013) Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. Immunity 38(1):27-40.
19. Kang S, et al. (2015) Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat Commun 6:7515.
20. Conos SA, Lawlor KE, Vaux DL, Vince JE, Lindqvist LM (2016) Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion. Cell Death Differ 23(11):1827-1838.
21. Chen KW, et al. (2014) The neutrophil NLRC4 inflammasome selectively promotes IL- 1β maturation without pyroptosis during acute Salmonella challenge. Cell Rep 8(2): 570-582.
22. Karmakar M, et al. (2015) Neutrophil IL-1beta processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux. J Immunol 194(4):1763-1775.
23. Russo HM, et al. (2016) Active caspase-1 induces plasma membrane pores that precede pyroptotic lysis and are blocked by lanthanides. J Immunol 197(4):1353-67.
24. Vince JE, et al. (2012) Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 36(2):215-227.
25. Muñoz-Planillo R, et al. (2013) K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6): 1142-1153.
26. He WT, et al. (2015) Gasdermin D is an executor of pyroptosis and required for interleukin- 1β secretion. Cell Res 25(12):1285-1298.
27. Kayagaki N, et al. (2015) Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526(7575):666-671.
28. Shi J, et al. (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526(7575):660-665.
29. Liu X, et al. (2016) Inflammasome-Activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535(7610):153-158.
30. Ding J, et al. (2016) Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535(7610):111-116.
31. Weinberg JM, Bienholz A, Venkatachalam MA (2016) The role of glycine in regulated cell death. Cell Mol Life Sci 73(11-12):2285-2308.
32. Fink SL, Cookson BT (2006) Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8(11):1812-1825.
33. Coll RC, et al. (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248-255.
34. Iyer SS, et al. (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 106(48):20388-20393.
35. Cullen SP, Kearney CJ, Clancy DM, Martin SJ (2015) Diverse activators of the NLRP3 inflammasome promote IL-1β secretion by triggering necrosis. Cell Reports 11(10): 1535-1548.
36. Martín-Sánchez F, et al. (2016) Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ 23(7):1219-1231.
37. Brough D, Rothwell NJ (2007) Caspase-1-dependent processing of pro-interleukin- 1beta is cytosolic and precedes cell death. J Cell Sci 120(Pt 5):772-781.
38. Khan N, Lawlor KE, Murphy JM, Vince JE (2014) More to life than death: molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling. Curr Opin Immunol 26:76-89.
39. Gaidt MM, et al. (2016) Human monocytes engage an alternative inflammasome pathway. Immunity 44(4):833-846.
40. Wolf AJ, et al. (2016) Hexokinase is an innate immune receptor for the detection of bacterial peptidoglycan. Cell 166(3):624-636.
41. Pétrilli V, et al. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14(9):1583-1589.
42. Newton K, et al. (2016) RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ 23(9):1565-1576.
43. Kitur K, et al. (2015) Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog 11(4):e1004820.
44. Lin J, et al. (2013) A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 3(1):200-210.
45. Paramel Varghese G, et al. (2016) NLRP3 inflammasome expression and activation in human atherosclerosis. J Am Heart Assoc 5(5):e003031.
46. Sheedy FJ, Moore KJ (2013) IL-1 signaling in atherosclerosis: sibling rivalry. Nat Immunol 14(10):1030-1032.
47. Ofengeim D, et al. (2015) Activation of necroptosis in multiple sclerosis. Cell Reports 10(11):1836-1849.
48. Jha S, et al. (2010) The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci 30(47):15811-15820.
49. Inoue M, Shinohara ML (2013) The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. Immunology 139(1):11-18.
50. Smith CC, et al. (2007) Necrostatin: A potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21(4):227-233.
51. Toldo S, et al. (2012) Recombinant human interleukin-1 receptor antagonist provides cardioprotection during myocardial ischemia reperfusion in the mouse. Cardiovasc Drugs Ther 26(3):273-276.
52. Degterev A, et al. (2005) Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1(2):112-119.
53. Northington FJ, et al. (2011) Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 31(1):178-189.
54. Brough D, Tyrrell PJ, Allan SM (2011) Regulation of interleukin-1 in acute brain injury. Trends Pharmacol Sci 32(10):617-622.
55. Bakker PJ, et al. (2014) A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion. Am J Pathol 184(7):2013-2022.
56. McComb S, et al. (2012) cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ 19(11):1791-1801.
57. Newton K, Sun X, Dixit VM (2004) Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Tolllike receptors 2 and 4. Mol Cell Biol 24(4):1464-1469.
58. Brydges SD, et al. (2009) Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30(6):875-887.
59. Kuida K, et al. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin- 1 beta converting enzyme. Science 267(5206):2000-2003.
60. Kayagaki N, et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479(7371):117-121.
61. Beilharz M, De Nardo D, Latz E, Franklin BS (2016) Erratum to: Measuring NLR oligomerization II: detection of ASC speck formation by confocal microscopy and immunofluorescence. Methods Mol Biol 1417:E1.
62. Schindelin J, et al. (2012) Fiji: An open-source platform for biological-image analysis. Nat Methods 9(7):676-682.